Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Interprets Echocardiograms in Minutes

By HospiMedica International staff writers
Posted on 27 Jun 2025

Cardiologists use echocardiography to diagnose a range of functional or structural abnormalities of the heart. More...

Using often over 100 videos and images that capture different parts of the heart, echocardiographers make dozens of measurements, such as the heart's size and shape, ventricle thickness, and the movement and function of each heart chamber, to assess patient heart health. Now, a new study has shown that an artificial intelligence (AI)-enabled tool can interpret echocardiograms with a high degree of accuracy in just a few minutes.

In the study led by Yale School of Medicine (YSM, New Haven, CT, USA), the researchers found that the AI tool, PanEcho, could perform 39 diagnostic tasks based on multi-view echocardiography and accurately detect conditions such as severe aortic stenosis, systolic dysfunction, and left ventricle ejection fraction, among others. This study builds on previous publications that demonstrated the technology’s accuracy. PanEcho was developed using 999,727 echocardiographic videos collected from Yale New Haven Health patients between January 2016 and June 2022. Researchers then validated the tool using studies from 5,130 Yale New Haven Health patients as well as three external data cohorts. To validate the model’s accuracy with point-of-care ultrasounds, the researchers used imaging from the Yale New Haven Hospital emergency department, which performs point-of-care ultrasounds as part of routine care.

While PanEcho is not yet available for clinical use, the paper published in JAMA discusses several potential future clinical applications of the technology. For instance, echocardiographers could utilize the tool as a preliminary reader to help assess images and videos in the echocardiography lab. It could also serve as a second set of eyes to help identify potentially missed abnormalities in existing databases. The researchers also note that this technology could be particularly valuable in low-resource settings, where access to equipment and skilled echocardiographers is limited. In these environments, clinicians often rely on handheld, point-of-care ultrasound devices, which produce lower-quality imaging that can be more challenging to interpret. The team is now working to conduct studies to assess how using the tool might change patient care in the echocardiography laboratory at Yale. The full model and weights are available via open source, and the research team is encouraging other investigators to test the model using their echocardiographic studies and make improvements.

“The tool can now measure and assess a wide range of heart conditions, making it much more attractive for future clinical use,” said Evangelos K. Oikonomou, MD, DPhil, clinical fellow (cardiovascular medicine) and co-first author of the study. “While it is highly accurate, it can be less interpretable than the read from a clinician. It’s still an algorithm and it requires human oversight.”

Related Links:
Yale School of Medicine 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.